Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Giving the drugs in different combinations may kill more tumor
cells.
PURPOSE: This randomized phase II trial is studying combination chemotherapy containing
irinotecan and oxaliplatin to see how well it works compared to two standard combination
chemotherapy regimens in treating patients with unresectable metastatic colorectal cancer.